It's no secret that pharma companies are struggling to protect themselves from cyberattacks amid the pandemic. Data breaches are costing the sector around US$5m a year, while one in 10 pharma companies are at risk of a ransomware attack, exacerbated by a perfect storm of shifting to remote working, increased growth, antiquated OT systems and a lack of cybersecurity skills.
Watch Now
The pandemic was a unique time in our industry where there was a perfect storm of need, money, collaboration, and trial patients all available in abundance. There was an atmosphere of all hands, and resources, on deck in the race to a COVID-19 vaccine.
Watch Now
Biopharma-asia
Hot Melt Extrusion (HME) is an established processing technology that can be used for the development of paediatric formulations. The processing of lipids via HME has been proved ideal for high drug loaded dosage forms with sustained release of drugs. The study investigates the effect of the lipid type and the food grade on the dissolution rates of extruded pellets or extemporaneous formulations.
Watch Now
Despite increases in cyber security investment, ransomware remains a persistent threat to healthcare operations. Join Akamai for a discussion on how microsegmentation can prevent adversarial attack methodologies from deployment of the ransomware itself.
Watch Now